Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Experts note that the use of chemotherapy can indicate cancer spread beyond its origin, potentially reflecting the stage, aggressiveness, or progression potential of the disease.
Gastroenterology July 24th 2024
Epoch Health
Recent research from Brown University suggests that the SARS-CoV-2 spike protein could interfere with cancer treatment efficacy by affecting the p53 gene’s ability to suppress tumor growth and repair DNA.
Allergy & Immunology May 1st 2024
Cancer Therapy Advisor
Explore new horizons in advanced hepatocellular carcinoma treatment with emerging data on lenvatinib and cisplatin’s potential efficacy as a second-line therapy and the promising triple combination therapy showing significant response rates.
Oncology, Medical April 1st 2024
Healthgrades for Professionals
Explore key points for patient communication on chemotherapy, offering a clear framework to discuss treatment goals, processes, and side effects, enhancing patient understanding and engagement in their care journey.
Hematology/Oncology April 1st 2024
Hematology Advisor
In a recent phase 3 trial, a low-dose chemotherapy regimen demonstrated noninferior efficacy to standard-dose regimens in pediatric AML patients, while significantly reducing non-hematologic toxicities, an important consideration in pediatric oncology.
Hematology January 22nd 2024
DocWire News
In a recent study, researchers found that, although pembrolizumab increased the pathological complete response in gastric cancer patients, it did not significantly improve event-free survival.
Gastroenterology January 16th 2024